Αποτελέσματα Αναζήτησης
Treatment with baclofen (30 mg/day, open-label) reduced alcohol consumption and severity of alcohol dependence in alcohol-dependent individuals with alcohol-related liver problems. [ 45 ] Treatment with baclofen (50 mg/day) was not superior to placebo in reducing alcohol drinking or craving in alcohol-dependent individuals.
- Treatment Interventions for Women With Alcohol Use Disorder
Treatment for co-occurring disorders may be indicated for...
- Treatment Interventions for Women With Alcohol Use Disorder
20 Μαΐ 2020 · The FDA has approved three medications for alcohol use disorder: naltrexone, acamprosate, and disulfiram. Additionally, other medications including gabapentin, baclofen, topiramate, and ondansetron show promise off-label for treating alcohol use disorder.
Treatment for co-occurring disorders may be indicated for the many women with AUD who present with additional mental health concerns. Interventions that address the co-occurrence of AUD with trauma and PTSD, mood disorders, and borderline personality disorder may be especially relevant for women.
15 Μαρ 2021 · While researchers and psychiatrists have used Prazosin sporadically for nearly a decade to treat patients with AUD, new research out of Yale shows that it can help patients significantly reduce...
1 Μαΐ 2018 · Sensible drinking limit (from 7 to 13 drinks per week) was present in 7% of premenopausal women, 11% of postmenopausal women under 70 years of age and in 14% of the women above 70 years of age.
Psychotherapy is the mainstay of treatment for alcoholism, while few drugs approved by legislators are available in the augmentation of this treatment, such as acamprosate, disulfiram, and naltrexone, approved by the FDA, and nalmefene by the EMA.
20 Ιουλ 2017 · Two complementary systematic reviews in older populations to identify: (1) Interventions to prevent or reduce excessive alcohol consumption; (2) Interventions as (1) also reporting cognitive or dementia outcomes. Alcohol dependence treatment was excluded. Protocols were pre-registered on PROSPERO [6 – 8].
